News from wilson therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 22, 2015, 05:00 ET

Wilson Therapeutics Announces the Appointment of Dr. Carl Bjartmar as Chief Medical Officer

 Wilson Therapeutics AB, a privately-held biopharmaceutical company developing novel treatments for patients with Wilson's Disease, today...

Jul 02, 2015, 05:00 ET

Wilson Therapeutics Appoints Hans Schikan to its Board of Directors

 Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced the appointment of Hans Schikan to its board of directors....

Jun 17, 2015, 05:00 ET

Wilson Therapeutics Announces Support of the BIG WOW to Raise Awareness of Wilson's Disease

Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG...

May 06, 2015, 05:00 ET

Wilson Therapeutics To Present As A "Next Wave" Company During BioEquity 2015 Conference In Vienna On May 19th

 Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that CEO Jonas Hansson has been invited to present...

Apr 16, 2015, 05:00 ET

Wilson Therapeutics Announces Presentation Of WTX101-201 Phase 2 Study At The EASL 50th International Liver Congress 2015

Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical...

Nov 17, 2014, 06:00 ET

Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients

 Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced the start of a Phase 2 clinical study to evaluate...

Apr 16, 2014, 03:00 ET

Wilson Therapeutics Secures $40 Million Private Financing To Advance Late Stage Development Program For Wilson's Disease

 Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors,...

Jan 13, 2014, 17:01 ET

Wilson Therapeutics Announces Successful Filing of U.S. IND to Advance WTX101 Development Program for Wilson Disease

 Wilson Therapeutics, a privately-held biopharmaceutical company, today announced that it has successfully filed an Investigational New Drug...